3 completed, 1 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
Follow CX-8998: new trials by email Literature Review of CX-8998 trials Research Report on CX-8998
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease Placebo, Suvecaltamide - Parkinson Disease, Tremor | Phase 2 | Completed | Jazz Pharmaceuticals | 169 | 2022-12-01 | 2026-01-15 |
| A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease CX-8998, Placebo - Parkinson's Disease, Tremor | Phase 2 | Withdrawn | Jazz Pharmaceuticals | 2019-12-01 | 2021-05-28 | |
| CX-8998 for Absence Seizures CX-8998 - Epilepsy | Phase 2 | Completed | Jazz Pharmaceuticals | 7 | 2018-02-25 | 2022-09-08 |
| A Phase 2 RCT Study of CX-8998 for Essential Tremor CX-8998, Placebo - Essential Tremor | Phase 2 | Completed | Jazz Pharmaceuticals | 95 | 2017-08-29 | 2021-11-23 |
Movement Disorders (2) · Parkinson Disease (2) · Tremor (2) · Epilepsy (1) · Epilepsy, Idiopathic Generalized (1) · Essential Tremor (1) · Seizures (1)
United States (3) · Germany (1) · Poland (1) · Spain (1)